Direct and indirect impact on rotavirus positive and all-cause gastroenteritis hospitalisations in South Australian children following the introduction of rotavirus vaccination

Vaccine

Volumn 29, Issue 29-30, 2011, Pages 4663-4667

  Clarke, Michelle F ^a   Davidson, Geoffrey P ^b   Gold, Michael S ^a   Marshall, Helen S ^a  

^a WOMEN S AND CHILDREN S HOSPITAL   (Australia)

^b UNIVERSITY OF ADELAIDE   (Australia)

Author keywords

Gastroenteritis; Impact; Rotavirus; Rotavirus vaccine

Indexed keywords

ROTAVIRUS VACCINE;

ALL CAUSE GASTROENTERITIS; ARTICLE; AUSTRALIA; CHILD; CHILD HOSPITALIZATION; DISEASE SEVERITY; FEMALE; GASTROENTERITIS; HIGH RISK POPULATION; HOSPITAL ADMISSION; HUMAN; INFANT; MAJOR CLINICAL STUDY; MALE; MEDICAL RECORD REVIEW; PRESCHOOL CHILD; PRIORITY JOURNAL; RETROSPECTIVE STUDY; ROTAVIRUS; ROTAVIRUS GASTROENTERITIS; ROTAVIRUS INFECTION; VACCINATION; VIRAL GASTROENTERITIS;

EID: 79960631407     PISSN: 0264410X     EISSN: 18732518     Source Type: Journal    
DOI: 10.1016/j.vaccine.2011.04.109     Document Type: Article

References (23)

1. Parashar UD, Gibson CJ, Bresee JS, Glass RI. Rotavirus and severe childhood diarrhea. Emerg Infect Dis 2006;12(2):304-6.
2. Galati JC, Harsley S, Richmond P, Carlin JB. The burden of rotavirus-related illness among young children on the Australian health care system. Aust N Z J Public Health 2006;30(5):416-22.
3. Velazquez RF, Matson DO, Calva JJ, Guerrero L, Morrow AL, Carter-Cambell S, et al. Rotavirus infections in infants as protection against subsequent infections. N Engl J Med 1996;335:1022-8.
4. Hull BP, Mahajan D, Dey A, Menzies R, McIntyre PB. Immunisation coverage annual report, 2008. Commun Dis Intell 2010;34(3).
5. RotaTeq® prescribing information. Merck& Co Inc.; 2009.
6. Santos N, Hoshino Y. Global distribution of rotavirus serotypes/genotypes and its implication for the development and implementation of an effective rotavirus vaccine. Rev Med Virol 2005;15(1):29-56.
7. Chang HG, Smith PF, Tserenpuntsag B, Markey K, Parashar U, Morse D. Reduction in hospitalizations for diarrhea and rotavirus infections in New York state following introduction of rotavirus vaccine. Vaccine 2010;28(3):754-8.
8. Sahni LC, Boom JA, Patel MM, Baker CJ, Rench MA, Parashar UD, et al. Use of an immunization information system to assess the effectiveness of pentavalent rotavirus vaccine in US children. Vaccine 2010;28(38):6314-7.
9. Boom JA, Tate JE, Sahni LC, Rench MA, Hull JJ, Gentsch JR, et al. Effectiveness of pentavalent rotavirus vaccine in a large urban population in the United States. Pediatrics 2010;125:e199-207.
10. Wang FT, Mast C, Glass RJ, Loughlin J, Seeger JD. Effectiveness of the pentavalent rotavirus vaccine in preventing gastroenteritis in the United States. Pediatrics 2010;125(2):e208-13.
11. Parashar UD, Glass RI. Rotavirus vaccines - early success, remaining questions. N Engl J Med 2009;360(11):1063-5.
12. Swiatek DL, Palombo EA, Lee A, Coventry MJ, Britz ML, Kirkwood CD. Characterisation of G8 human rotaviruses in Australian children with gastroenteritis. Virus Res 2010;148:1-7.
13. Kirkwood CD, Cannan D, Bogdanovic-Sakran N, Bishop RF, Barnes GL, National Rotavirus Surveillance Group. Australian Rotavirus Surveillance Program annual report 2006-07. Commun Dis Intell 2007;31(4):375-9.
14. Kirkwood C, Boniface K, Bishop R, Barnes G, Australian Rotavirus Surveillance Group. Australian Rotavirus Surveillance Program annual report 2008/2009. Commun Dis Intell 2009;33(4):382-8.
15. Lambert SB, Faux CE, Hall L, Birrell FA, Peterson KV, Selvey CE, et al. Early evidence for direct and indirect effects of the infant rotavirus program in Queensland. MJA 2009;191(3):157-60.
16. Belshaw DA, Muscatello DJ, Ferson MJ, Nurkic A. Rotavirus vaccination one year on.. Commun Dis Intell 2009;33(3):337-40.
17. Field EJ, Vally H, Grimwood K, Lambert S. Pentavalent rotavirus vaccine and prevention of gastroenteritis hospitalizations in Australia. Pediatrics 2010;126(3):506-12.
18. Buttery JP, Lambert SB, Grimwood K, Nissen MD, Field EJ, Macartney KK, et al. Reduction in rotavirus-associated acute gastroenteritis following introduction of rotavirus vaccine into Australia's National Childhood vaccine schedule. Pediatr Infect Dis J 2011;30(Suppl. 1):S25-9.
19. Macartney KK, Porwal M, Dalton D, Cripps T, Maldigri T, Isaacs D, et al. Decline in rotavirus hospitalisations following introduction of Australia's national rotavirus immunisation programme. J Paediatr Child Health 2011, doi:10.1111/j.1440-1754.2010.01953.x (ahead of print).
20. Australian Bureau of Statistics, 3201.0 - Population by Age and Sex, Australian States and Territories, Jun 2008 Release 2009. Table 4: Estimated Resident Population by single age, South Australia.
21. Staat MA, Rice MA, Donauer S, Payne DC, Bresee JS, Mast TC, et al. Estimating the rotavirus hospitalization disease burden and trends, using capture-recapture methods. Pediatr Infect Dis J 2010;29(12):1083-6.
22. Carlin JB, Chondros P, Masendycz P, Bugg H, Bishop RF, Barnes GL. Rotavirus infection and rates of hospitalisation for acute gastroenteritis in young children in Australia, 1993-1996. Med J Aust 1998;169:252-6.
23. Campbell SJ, Nissen MD, Lambert SB. Rotavirus epidemiology in Queensland during the pre-vaccine era. Commun Dis Intell 2009;33(2):204-8.